ArticleBlood advances2026

Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom macroglobulinemia.

Nickolas Tsakmaklis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.